Free Trial
NASDAQ:TLSIW

TriSalus Life Sciences (TLSIW) Stock Price, News & Analysis

$1.51
+0.13 (+9.42%)
(As of 11/4/2024 ET)

About TriSalus Life Sciences Stock (NASDAQ:TLSIW)

Key Stats

Today's Range
$1.20
$1.51
50-Day Range
$0.81
$1.50
52-Week Range
$0.10
$2.23
Volume
5,803 shs
Average Volume
11,464 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Receive TLSIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSIW Stock News Headlines

Tim Sykes’ Urgent Trade Alert: “Make this move now”
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
TriSalus Life Sciences initiated with an Outperform at Northland
TriSalus Life Sciences, Inc. Q1 Loss Climbs
See More Headlines

TLSIW Stock Analysis - Frequently Asked Questions

TriSalus Life Sciences' stock was trading at $1.19 at the beginning of the year. Since then, TLSIW shares have increased by 26.9% and is now trading at $1.51.
View the best growth stocks for 2024 here
.

Shares of TLSIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:TLSIW
Fax
N/A
Employees
107
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$24.74 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:TLSIW) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners